Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 25,173Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Incyte Biosciences Distribution B.V.

02 1Incyte Biosciences Distribution Bv

03 1Incyte Biosciences International S?rl

04 14Novartis Europharm Limited

05 4Novartis Europharm Limited (1)

06 5Novartis Pharma Schweiz Ag

07 2Orifarm AS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Ruxolitinib

Brand Name : Opzelura g

Dosage Form : Cream

Dosage Strength : 15mg

Packaging :

Approval Date : 30/01/2025

Application Number : 69443

Regulatory Info : Allowed

Registration Country : Switzerland

blank

02

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 5mg

Packaging :

Approval Date : 27/12/2012

Application Number : 62126

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 15mg

Packaging :

Approval Date : 27/12/2012

Application Number : 62126

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 20mg

Packaging :

Approval Date : 27/12/2012

Application Number : 62126

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 10mg

Packaging :

Approval Date : 27/12/2012

Application Number : 62126

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Oral Solution

Dosage Strength : 5mg/ml

Packaging :

Approval Date : 27/03/2025

Application Number : 69722

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 10mg

Packaging :

Approval Date : 03/10/2014

Application Number : 20140311000017

Regulatory Info : Approved

Registration Country : Sweden

blank

08

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 15mg

Packaging :

Approval Date : 23/08/2012

Application Number : 20110602000170

Regulatory Info : Approved

Registration Country : Sweden

blank

09

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 20mg

Packaging :

Approval Date : 23/08/2012

Application Number : 20110602000187

Regulatory Info : Approved

Registration Country : Sweden

blank

10

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 5mg

Packaging :

Approval Date : 23/08/2012

Application Number : 20110602000163

Regulatory Info : Approved

Registration Country : Sweden

blank